Please login to the form below

Not currently logged in
Email:
Password:

respiratory disease

This page shows the latest respiratory disease news and features for those working in and with pharma, biotech and healthcare.

Novartis first to benefit from NICE advice on ‘patient preference’

Novartis first to benefit from NICE advice on ‘patient preference’

The advice was provided to Novartis, and looked at a patient preference study for people with respiratory condition chronic obstructive pulmonary disease (COPD).

Latest news

  • Novo spends $800m to buy biotech and 'glucose responsive insulin' tech Novo spends $800m to buy biotech and 'glucose responsive insulin' tech

    its  nanobodies platform would have, as its pipeline covers inflammation, haematology, respiratory disease and oncology.

  • AZ pushes harder into China with new joint venture AZ pushes harder into China with new joint venture

    Xiaolin Zhang, the current ICC head. The company’s starting portfolio includes candidates from AZ’s oncology, cardiovascular and metabolic disease and respiratory, said AZ.

  • Smart solutions Smart solutions

    Suboptimal real-world results are driven by a number of obstacles in the management of respiratory disease, with poor adherence at the top of the list. ... The standard of care in respiratory medicine has remained largely unchanged for several decades.

  • GSK targets COPD adherence with integrated inhaler sensors GSK targets COPD adherence with integrated inhaler sensors

    Hopes real-time patient experience data will improve clinical trial engagement. GlaxoSmithKline is set to begin a series of clinical trials focused on improving patient adherence to asthma and respiratory disease ... If it's a very cold day or there's a

  • AZ signs $1bn deal with Bicycle Therapeutics AZ signs $1bn deal with Bicycle Therapeutics

    Cambridge-based Bicycle's in-house programmes are targeted at cancer, but AZ's initial interest is in the development of bicyclic peptides for respiratory, cardiovascular and metabolic diseases, including inhaled ... Bicycle's focus so far has been in

More from news
Approximately 4 fully matching, plus 64 partially matching documents found.

Latest Intelligence

  • New models of NHS care – new models of pharma response? New models of NHS care – new models of pharma response?

    The region is now adopting population health models for musculoskeletal (MSK) respiratory disease, diabetes and cardiovascular disease. ... Echoing James Roach’s sentiment, she said: “Please don't wait to be asked, but make sure you're coming to us

  • Asthma: beyond the blue and the brown Asthma: beyond the blue and the brown

    Combine asthma with other respiratory diseases, including chronic obstructive pulmonary disease (COPD), and it contributes to more than 4 million deaths every single year, a stagnated figure that has seen no ... For innovation in respiratory medicine to

  • Digital disruption Digital disruption

    Starting with projects in schizophrenia and Parkinson’s disease, Lundbeck and IBM will also work together to identify potential new drug targets and alternative indications. ... and chronic disease management, starting with respiratory and central

  • Medicine, the arts and the events industry Medicine, the arts and the events industry

    At the launch of a revolutionary drug for respiratory diseases, members of the pharma sales force were voluntarily fitted with restraining vests which limited their movement. ... These elements combined to recreate the actual physical sensation of living

  • From measurement to management From measurement to management

    US Centres for Disease Control and Prevention definition: . Well-being integrates mental health (mind) and physical health (body) resulting in more holistic approaches to disease prevention and health. ... CV disease: 17.6m; cancer: 7.6m; respiratory:

More from intelligence
Approximately 0 fully matching, plus 10 partially matching documents found.

Latest appointments

  • emotive boosts its client services team emotive boosts its client services team

    Joining as a senior account director, Andy Parry has 9 years’ experience in healthcare communications and has worked on global brands in CNS, infectious diseases, respiratory and rare disease.

  • MyoKardia appoints COO and medical affairs VP MyoKardia appoints COO and medical affairs VP

    Prior to this, Dr Lee was therapeutic area head for cardiovascular, metabolic, respiratory and infectious disease programmes at Genentech. ... Their expertise and counsel will broaden our base of leadership and support our mission to change the world for

  • Karus names two division heads Karus names two division heads

    Most recently he was VP, global head – respiratory disease. In his new role Dr Finan will work on Karus' most advanced programme, a treatment for inflammatory disorders.

  • Aurora expands its team with three new hires Aurora expands its team with three new hires

    Mosley (pictured above right) joins the London agency as senior account director and arrives from Tonic Life Communications, where she worked across a number of therapeutic areas including rheumatology, respiratory and ... cardiovascular disease.

  • Oliver Rausch to lead translational research partnership efforts at NIHR Oliver Rausch to lead translational research partnership efforts at NIHR

    Efforts currently cover two areas, inflammatory respiratory disease and joint and related inflammatory diseases, both of which shall be overseen by Dr Rausch.

More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

  • What role for pharma in helping to deliver integrated care?

    In common with all Sustainability and Transformation Partnerships (STPs), ICSs have certain areas that they must focus on under the Long Term Plan, such as diabetes, cancer and respiratory disease.

  • Ben Hwang discusses innovative diagnostic real-time monitoring data-sensors

    Ben Hwang, MA, PhD, Chairman and CEO of Profusa, a company innovating in diagnostics and real-time disease monitoring, talks to us about how continuous data sensors could transform the way ... Profusa have recently received approval for their first

  • Exploring MINT: Part 2 - Indonesia

    Interestingly, the younger age profile does give the country a different disease profile to that of ‘older’ nations. ... Air pollution in urban areas is responsible for a high burden of respiratory disease.

  • GCI Health

    a presence across all social media platforms, a schedule of content to put the organisation at the forefront of the key issues in the management of respiratory disease, and executive committee

  • infill healthcare communication

    In particular, infill has expertise in oncology, neurology (in particular stroke and Parkinson’s disease), cardiology, endocrinology (diabetes), respiratory medicine, gastroenterology, women’s health, infectious diseases, as well as internal

More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics